MIT BOTULINUMTOXIN VORGEFÜLLTE SPRITZE

European patent · EP3236939 · In force

Register entry

Publication number
EP3236939
Application number
EP15823134
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Maintained in amended form
Filed
Dec 22, 2015
Published
Nov 1, 2017
Granted
Apr 1, 2020
Protection ends at the latest
Dec 21, 2035
Next annual fee due
Dec 31, 2026
IPC classes
A61K 9/00 (2006.01)
A61K 38/48 (2006.01)
A61K 47/26 (2006.01)
A61Q 19/08 (2006.01)
A61M 5/31 (2006.01)
A61M 5/315 (2006.01)
Priority
EP 14004394 23.12.2014
PCT application
PCT/EP2015/002602 22.12.2015
PCT publication
WO2016/102068 30.06.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jul 31, 2024

    Change

    Published in Swissreg on 31.07.2024

  4. Jan 9, 2024

    Change

    Published in Swissreg on 09.01.2024

  5. Mar 7, 2023

    Change

    Published in Swissreg on 07.03.2023

  6. Mar 7, 2023

    Change

    Published in Swissreg on 07.03.2023

  7. Jan 4, 2023

    Change

    Published in Swissreg on 04.01.2023

  8. May 12, 2020

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 12.05.2020

1 earlier entry
  1. Apr 1, 2020

    Granted

    Published in Swissreg on 01.04.2020

Parties

Holder

Merz Pharma GmbH & Co. KGaA

Eckenheimer Landstrasse 100, 60318 Frankfurt am Main, DE

Agent

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventor

VOGT, Markus

60438 Frankfurt am Main, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.